CNBC   |  July 24, 2013

GlaxoSmithKline China charges update

CNBC's Eunice Yoon discusses the damage control coming out of GlaxoSmithKline, which says the charges out of China were disappointing and the company is commissioning its own review.

Share This:

Sorry, we do not have a transcript available for this video at this time.